| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789246 | Practical Radiation Oncology | 2018 | 40 Pages |
Abstract
Stereotactic body radiation therapy (SBRT) is increasingly being used for the management of clinically localized prostate cancer. This trend, combined with the decline in the use of brachytherapy, has pushed issues and questions regarding the use of SBRT to the forefront. A systematic literature review was conducted to establish the current evidence of biochemical and toxicity outcomes of SBRT in high-risk prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alejandro MD, Mack MD FACR FASTRO,